生长激素释放抑制因子类似物的研究进展

孙滨源;田桂玲;叶蕴华

中国药学杂志 ›› 1998, Vol. 33 ›› Issue (06) : 327-330.

中国药学杂志 ›› 1998, Vol. 33 ›› Issue (06) : 327-330.
综述

生长激素释放抑制因子类似物的研究进展

  • 孙滨源; 田桂玲; 叶蕴华
作者信息 +
文章历史 +

摘要

目的:介绍生长激素释放抑制因子(SRIF)类似物的研究进展。方法:主要根据近年文献,综述SRIF的构效关系研究及其类似物的设计,SRIF受体的研究及其类似物的临床应用等。结果与结论:许多有活性的类似物已被发现,一部分已应用于临床。这类药物在内分泌系统的调控、诊断及治疗肿瘤方面,有良好的应用前景。

关键词

生长激素释放抑制因子 / 多肽药物 / 药物设计

引用本文

导出引用
孙滨源;田桂玲;叶蕴华. 生长激素释放抑制因子类似物的研究进展[J]. 中国药学杂志, 1998, 33(06): 327-330

参考文献

1 Brazeau P,Vale W,Burgus R,et al.Hypethalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.Science.1973,179(4068):77. 2 Edwards WB,Fidds CG,Anderson CJ.el al.Generally applicable,convenient solid-phase synthesis and receptor affinities of octreotide analogs.J Med Chem,1994,37(22):3749. 3 Bauer W,Briner U,Doepfner W,el al.SMS 201-995:A very potent and selective octapeptide analogue of somato-statin with prolonged action.Life Sci,1982,31(11):1133. 4 Liehow C,Lee MT,Schally A.Antitumor effects of so-matostatin mediated by the stimulation of tyrosine phos-phatsse.Metabolism,1990,39(9,Suppl2):163. 5 Veber DF,Freidinger RM,Perlow DS,et al.A potent cyclic hexapeptide analogue of somatostatin.Nature,1981,292(5818):55. 6 Jaspers H,Horvath A,Merzo I,el al.Conformational study of a series of somatistatin analogues with antitumor and/or GH inhibitory activity.Int J Pept Protein Res,1994,43(3):271. 7 Verheyden P,Francq W,Pepermans H,et al.Conformational study of a somatostatin analogue in DMSO/Water by2 D NMR.Biopolymers,1990,30(7/8):855. 8 Huang Z,He Y,Raynor K,et al.Main chain and side chain chiral methylated somatostatin analogs:syntheses and conformaimnal analyses.Jam Chem Soc,1992,114(24):9390. 9 Rivier J,Brown M,ValW D-Tro8-somatctatin:an ana-log of somatostatin more potent than the native mulecule.Biochem Biophys Res Commun,1975,65(2):746. 10 Goodman M,Chorev M.A dozen years of Retro-lnverso peptidomimeties.Acc Chem Res,1993,26(5):266. 11 Veber DF,Holly FW,Nutt RF,et al.Highly active cyecic and bicyclic somatostatin analogues of reduced ring size.Nature,1979,280(5722):512. 12 Gramberg D,Weber C,Beeli R,et al.Synthesis of a type-Vlb-turn peptide mimetic and its incorporation into a high-affinity somatostatin recegor ligand Heir Chim Acta,1995,78(6):1588. 13 HirschmannR,Yao W,Arison B,et al.The first synthe-sis of a tricyclic homodetic peptide empbying coordinated orthogonal protection.Tetrahedron Lett,1996,37(32):5637. 14 Veber DF,Saperstein R,Nutt RF,et al.A super active cyclic hexapeptide analog of somatostatin.Life Sci,1984,34(14):1371. 15 Bakker WH,Albert R,Bruns C,et al [111 In-DTPA-D-Phe1]-octreotide,a potential radiopharmaceutical for imoging of somatostatin receptor-positive tumors:synthesis,ra-diolabeliog and in vitro validation Life Sci,1991,49(22):1583. 16 Kim SH,Dong JZ,Gordon TD,eg al.Potent somatostatin analogs containing N-terminal modifications.Ln:Kaumaya PTP,Hodges RS,eds.Peptide:Chemistry,Structure and Biology,proceedings of the Fourteenth American Pep-tide Symposium.England:Mayflower Scientific Ltd.,1996:241~243. 17 Albert R,Marbaeh P,Bauer W,et al.SDZ CO 611:a highly potent glyated analog of somatostatin with improved oral avtivity.Life Sci,1993,53(6):517. 18 Lewis L,Bruna C.Synthesis of somatostatin analogues in-corporating nucleo amino acids.Tetrahedron.1994,50(25):7485. 19 Hirschmann R,Nicolaou KC,Pietranico S,et al.Nonpep-tidal peptidomimetics with a b-D-glucose scaffolding.A par-tial somatostatin agonist bearing a close structural relation-ship to a potent,selective substance P antagonist.J Am Chem Soc,1992,114(23):9217. 20 Patel YC,Greenwood MT,Panetta R,et al.The somato-shatin receptor family Life Sci.1995,57(13):1249. 21 Patel YC,Srikant CB.Subtype selectivity of peptide analogs for all five cloned hunmn somatostatin receptors(hsstr 1-5) Endocrinology,1994,135(6):2814. 22 Taylor JE,Bogden AE,Moreau JP,et al.In vitro and in vivo inhibition of human small cell lung carcinorma(NCI-H69)growth by a somatoatatin analogue.Biochen Biophys Res Commun,1988,153(1):81. 23 CaiRZ,Stoke B,LuR.Et al.Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.Proc Natl Acad Sci USA,1986,83(6):1896. 24 Schally AV.Oncologieal applications of somatostatin ana-logues.Cancer Res,1988,48(24):6977. 25 Harris AG.Future medical prospects for sandostatin.Metabolism,1990,39(9):180.

52

Accesses

0

Citation

Detail

段落导航
相关文章

/